UB Paderborn / Katalog / Suche / in CDI

In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria

Journal of antimicrobial chemotherapy, 2017-05, Vol.72 (5), p.1373-1385

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae

Journal of antimicrobial chemotherapy, 2019-04, Vol.74 (4), p.953-960

2019

Link zum Volltext

Verfügbarkeit prüfen

Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2011-01, Vol.55 (1), p.390-394

2011

Link zum Volltext

Verfügbarkeit prüfen

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline

International journal of antimicrobial agents, 2011-05, Vol.37 (5), p.415-419

2011

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2016-06, Vol.60 (6), p.3840-3844

2016

Link zum Volltext

Verfügbarkeit prüfen

Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014

Euro surveillance : bulletin européen sur les maladies transmissibles, 2016-12, Vol.21 (50), p.1

2016

Link zum Volltext

Verfügbarkeit prüfen

Doripenem versus Pseudomonas aeruginosa In Vitro: Activity against Characterized Isolates, Mutants, and Transconjugants and Resistance Selection Potential

Antimicrobial Agents and Chemotherapy, 2004-08, Vol.48 (8), p.3086-3092

2004

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria

Pharmaceutics, 2021-12, Vol.13 (12), p.2186

2021

Link zum Volltext

Verfügbarkeit prüfen

Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (3), p.306-311

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative Activities of Doripenem versus Isolates, Mutants, and Transconjugants of Enterobacteriaceae and Acinetobacter spp. with Characterized β-Lactamases

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1313-1319

2004

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria

Antimicrobial agents and chemotherapy, 2020-11, Vol.64 (12)

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of the Oxazolidinone RWJ-416457 against Linezolid-Resistant and -Susceptible Staphylococci and Enterococci

Antimicrobial Agents and Chemotherapy, 2007-03, Vol.51 (3), p.1112-1114

2007

Link zum Volltext

Verfügbarkeit prüfen

Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2286-2290

2013

Link zum Volltext

Verfügbarkeit prüfen

Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases

Journal of antimicrobial chemotherapy, 2021-01, Vol.76 (2), p.434-442

2021

Link zum Volltext

Verfügbarkeit prüfen

Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae

Journal of antimicrobial chemotherapy, 2013-08, Vol.68 (8), p.1825-1831

2013

Link zum Volltext

Verfügbarkeit prüfen

Activity of cefepime/zidebactam (WCK 5222) against ‘problem’ antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory

Journal of antimicrobial chemotherapy, 2021-05, Vol.76 (6), p.1511-1522

2021

Link zum Volltext

Verfügbarkeit prüfen

Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria

Journal of antimicrobial chemotherapy, 2021-01, Vol.76 (1), p.160-170

2021

Link zum Volltext

Verfügbarkeit prüfen

In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5324-5330

2015

Link zum Volltext

Verfügbarkeit prüfen

Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli

International journal of antimicrobial agents, 2023-05, Vol.61 (5), p.106776-106776, Article 106776

2023

Link zum Volltext

Verfügbarkeit prüfen

Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales

Journal of antimicrobial chemotherapy, 2022-09, Vol.77 (10), p.2772-2778

2022

Link zum Volltext

Verfügbarkeit prüfen

Activity of faropenem against cephalosporin-resistant Enterobacteriaceae

Journal of antimicrobial chemotherapy, 2007-05, Vol.59 (5), p.1025-1030

2007

Link zum Volltext

Verfügbarkeit prüfen

Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing Enterobacterales

Journal of antimicrobial chemotherapy, 2021-12, Vol.77 (1), p.98-111

2021

Link zum Volltext

Verfügbarkeit prüfen

Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae

Journal of antimicrobial chemotherapy, 2013-08, Vol.68 (8), p.1825-1831

2013

Link zum Volltext

Verfügbarkeit prüfen

Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance

International journal of antimicrobial agents, 2024-03, Vol.63 (3), p.107081-107081, Article 107081

2024

Link zum Volltext

Verfügbarkeit prüfen

Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilution

Journal of antimicrobial chemotherapy, 2022-06, Vol.77 (7), p.1916-1922

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria

Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae

Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014

Doripenem versus Pseudomonas aeruginosa In Vitro: Activity against Characterized Isolates, Mutants, and Transconjugants and Resistance Selection Potential

Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria

Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems

Comparative Activities of Doripenem versus Isolates, Mutants, and Transconjugants of Enterobacteriaceae and Acinetobacter spp. with Characterized β-Lactamases

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria

In Vitro Activity of the Oxazolidinone RWJ-416457 against Linezolid-Resistant and -Susceptible Staphylococci and Enterococci

Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa

Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases

Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae

Activity of cefepime/zidebactam (WCK 5222) against ‘problem’ antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory

Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria

In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase

Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli

Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales

Activity of faropenem against cephalosporin-resistant Enterobacteriaceae

Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing Enterobacterales

Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae

Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance

Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilution

Suchergebnisse filtern